Cosopt Solution/ Drops
Product Images NDC 82584-605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cosopt (NDC 82584-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cosopt 01)

FDA Label Image

Chemical Structure (Cosopt 02)

FDA Label Image

Figure A (Cosopt 03)

FDA Label Image

Figure B (Cosopt 04)

FDA Label Image

Principal Display Panel (10 mL Bottle Carton)

Principal Display Panel (10 mL Bottle Carton)
This is a product description for an ophthalmic solution named COSOPT. It contains 223mg/mL of dorzolamide hydrochloride that is equivalent to 0.20 mg dorzolamide (2%) and 6.8mg/mL of timolol maleate equivalent to 5mg timolol (0.5%). The product comes in a 10mL container and should be protected from light. It is manufactured and distributed by Thea Pharma Inc. The text also includes instructions for use, storage, and precautions against contamination. No Non-English text detected.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.